Surface Mucin-1 does not play a role in dendritic cell migration.
暂无分享,去创建一个
P. Delvenne | W. Germeraad | J. Caberg | G. Bos | P. Hubert | P. Roncarati | J. Vanderlocht | S. Cloosen | B. L. M. G. Senden-Gijsbers | Mariska B Huls
[1] Zhenglong Yuan,et al. Down-regulation of MUC1 in cancer cells inhibits cell migration by promoting E-cadherin/catenin complex formation. , 2007, Biochemical and biophysical research communications.
[2] A. Barakat,et al. MUC1 is involved in trophoblast transendothelial migration. , 2007, Biochimica et biophysica acta.
[3] J. Gratama,et al. Cancer specific Mucin‐1 glycoforms are expressed on multiple myeloma , 2006, British journal of haematology.
[4] P. Singh,et al. RNA Interference Suppression of MUC1 Reduces the Growth Rate and Metastatic Phenotype of Human Pancreatic Cancer Cells , 2006, Clinical Cancer Research.
[5] H. Shimizu,et al. Presence of Circulating CCR10+ T cells and Elevated Serum CTACK/CCL27 in the Early Stage of Mycosis Fungoides , 2006, Clinical Cancer Research.
[6] P. Krause,et al. Prostaglandin E2 Is Generally Required for Human Dendritic Cell Migration and Exerts Its Effect via EP2 and EP4 Receptors1 , 2006, The Journal of Immunology.
[7] Shinichi Watanabe,et al. IL-17 suppresses TNF-alpha-induced CCL27 production through induction of COX-2 in human keratinocytes. , 2005, The Journal of allergy and clinical immunology.
[8] B. Homey,et al. Chemokine networks in atopic dermatitis: traffic signals of disease , 2005, Current allergy and asthma reports.
[9] P. Delvenne,et al. E‐cadherin‐dependent adhesion of dendritic and Langerhans cells to keratinocytes is defective in cervical human papillomavirus‐associated (pre)neoplastic lesions , 2005, The Journal of pathology.
[10] P. Krause,et al. Prostaglandin E 2 Is Generally Required for Human Dendritic Cell Migration and Exerts Its Effect via EP 2 and EP 4 Receptors 1 , 2005 .
[11] J. Chow,et al. MUC1 Mediates Transendothelial Migration in vitro by Ligating Endothelial Cell ICAM-1 , 2005, Clinical & Experimental Metastasis.
[12] W. Germeraad,et al. Mucin-1 is expressed on dendritic cells, both in vitro and in vivo. , 2004, International immunology.
[13] Michael A. Hollingsworth,et al. Mucins in cancer: protection and control of the cell surface , 2004, Nature Reviews Cancer.
[14] Antonio Lanzavecchia,et al. Regulation of Dendritic Cell Migration to the Draining Lymph Node , 2003, The Journal of experimental medicine.
[15] J. Meza,et al. Contribution of the MUC1 tandem repeat and cytoplasmic tail to invasive and metastatic properties of a pancreatic cancer cell line. , 2003, Cancer research.
[16] J. Taylor‐Papadimitriou,et al. Form and pattern of MUC1 expression on T cells activated in vivo or in vitro suggests a function in T‐cell migration , 2003, Immunology.
[17] J. Meza,et al. Contribution of the MUC 1 Tandem Repeat and Cytoplasmic Tail to Invasive and Metastatic Properties of a Pancreatic Cancer Cell Line 1 , 2003 .
[18] J. Chung,et al. Fructose‐1,6‐diphosphate attenuates prostaglandin E2 production and cyclo‐oxygenase‐2 expression in UVB‐irradiated HaCaT keratinocytes , 2002, British journal of pharmacology.
[19] M. McGuckin,et al. MUC1 epithelial mucin (CD227) is expressed by activated dendritic cells , 2002, Journal of leukocyte biology.
[20] R. Förster,et al. Prostaglandin E2 is a key factor for CCR7 surface expression and migration of monocyte-derived dendritic cells. , 2002, Blood.
[21] R. Förster,et al. Prostaglandin E 2 is a key factor for CCR 7 surface expression and migration of monocyte-derived dendritic cells , 2002 .
[22] T. Brümmendorf,et al. Expression of MUC-1 epitopes on normal bone marrow: implications for the detection of micrometastatic tumor cells. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[23] P. Delvenne,et al. Colonization of in vitro-formed cervical human papillomavirus- associated (pre)neoplastic lesions with dendritic cells: role of granulocyte/macrophage colony-stimulating factor. , 1999, The American journal of pathology.
[24] J. Hugh,et al. MUC1 synthetic peptide inhibition of intercellular adhesion molecule-1 and MUC1 binding requires six tandem repeats. , 1998, Cancer research.
[25] B. Longenecker,et al. Expression of MUC1 mucin on activated human T cells: implications for a role of MUC1 in normal immune regulation. , 1998, Cancer research.
[26] Y. Yamaguchi,et al. EBI1/CCR7 is a new member of dendritic cell chemokine receptor that is up-regulated upon maturation. , 1998, Journal of immunology.
[27] L. Pilarski,et al. The breast mucin MUCI as a novel adhesion ligand for endothelial intercellular adhesion molecule 1 in breast cancer. , 1996, Cancer research.
[28] J. Dekker,et al. Mucin gene structure and expression: protection vs. adhesion. , 1995, The American journal of physiology.
[29] R. Dahiya,et al. Heterogeneity of mucin gene expression in normal and neoplastic tissues. , 1993, Cancer research.